Revance Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Revance Stock Summary

Revance competes with DiaMedica Therapeutics, Akero Therapeutics, Nuvalent, Immunocore Holdings, and Ventyx Biosciences. Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Revance Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 495 people.

Revance Key Financial Ratios

Revance Key Balance Sheet Accounts

Revance Key Income Statement Accounts

Revance Key Cash Accounts

Revance Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Revance's current stock value. Our valuation model uses many indicators to compare Revance value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revance competition to find correlations between indicators driving Revance's intrinsic value. More Info.Revance is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Revance's Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Revance's earnings, one of the primary drivers of an investment's value.

Revance Systematic Risk

Today, most investors in Revance Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Revance's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Revance growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Revance help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Revance. We use our internally-developed statistical techniques to arrive at the intrinsic value of Revance based on widely used predictive technical indicators. In general, we focus on analyzing Revance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Revance's daily price indicators and compare them against related drivers.

When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.